<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01435850</url>
  </required_header>
  <id_info>
    <org_study_id>D10056-2-F</org_study_id>
    <nct_id>NCT01435850</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of the SL PLUS and the SL PLUS MIA Hip Stem</brief_title>
  <acronym>SL-PLUS</acronym>
  <official_title>&quot;Enfoncement de la Tige SL-PLUS et de la Tige SL-PLUS MIA:Etude Comparative&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew Orthopaedics AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial using two types of hip stems, SL PLUS MIA (control group) and SL
      PLUS (study group).

      We compare primary and secondary stability of both hip stems for radiographic outcome using
      EBRA (Ein-Bild-Roentgen-Analyse) after a two year follow-up period.

      Further, we compare all differences in clinical outcome using Harris Hip Score, Oxford hip
      score and radiographic findings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a monocentric study, randomized and controlled including two types of hip
      stems: SL PLUS MIA (control group) and SL PLUS (study group).

      Each group will include 45 patients where a number of 5 patients for each group calculated
      extra in case of loss.

      Patients will be followed after

        -  6 weeks

        -  6 months

        -  12 months

        -  24 months. Radiographs are taken in a-p and lateral view using a standard protocol.
           Primary and secondary stability of both hip stems will be analyzed using the EBRA
           software (Ein-Bild-Roentgen-Analyse, University of Innsbruck, Austria) after the
           completion of the two year follow-up.

      Further, we compare all differences in clinical outcome using Harris Hip Score, Oxford hip
      score and radiographic findings such as radiolucent lines.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stability of primary total hip arthroplasty</measure>
    <time_frame>24 months</time_frame>
    <description>Study compares the stability of two types of hip stems using the Femoral Component Analysis (FCA-EBRA)method. 4 images of a-p pelvic view will be collected over a 2-year period: at 6 weeks, 6, 12 and 24 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxford Hip Score</measure>
    <time_frame>24 months</time_frame>
    <description>According to Delaunay C, Cross-cultural adaptations of the Oxford-12 HIP score to the French speaking population, Orthop Traumatol Surg Res. 2009 Apr;95(2):89-99. Epub 2009 Apr 3.
Oxford Hip Score will be measured pre-operatively, after 6 weeks, 6, 12 and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>24 months</time_frame>
    <description>Harris Hip Score will be measured pre-operatively, after 6, 12 and 24 months. No measurement after 6 weeks.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Coxarthrosis</condition>
  <arm_group>
    <arm_group_label>HIP STEM SL PLUS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>study group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIP STEM SL PLUS MIA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>primary total hip arthroplasty</intervention_name>
    <description>All patients eligible to the study criteria will be included. A total hip arthroplasty unilateral will be performed.</description>
    <arm_group_label>HIP STEM SL PLUS</arm_group_label>
    <arm_group_label>HIP STEM SL PLUS MIA</arm_group_label>
    <other_name>SL-PLUS, SL-PLUS MIA, Lateralized hip stem</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient needs primary total hip arthroplasty with SL-PLUS (standard or lateralized
             depending on bone morphology)

          -  Age at surgery : 18-80 years old

          -  Patient has social security number

          -  Patient gives Informed Consent (IC) by signing the IC form and patient is willing to
             attend the follow-up control

        Exclusion Criteria:

          -  Patient's BMI is over 35

          -  Patient has bone tumors that can affect implant stability

          -  Patient needs cortical steroid treatment

          -  Patient needs hip revision arthroplasty

          -  Patient has general inflammation that could affect bone quality

          -  Patients classified Charnley C
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henri Migaud, MD, Pr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Salengro, Service d'Orthop√©die C</name>
      <address>
        <city>Lille Cedex</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2011</study_first_submitted>
  <study_first_submitted_qc>September 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2011</study_first_posted>
  <last_update_submitted>April 1, 2015</last_update_submitted>
  <last_update_submitted_qc>April 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hip arthroplasty</keyword>
  <keyword>primary stability</keyword>
  <keyword>secondary stability</keyword>
  <keyword>EBRA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

